Logo Logo Logo Logo Logo
  • About
    • Board & Management
    • Business Development
  • Diagnostic Areas
    • COVID-19
    • Intelligent Innovation
  • Products & Solutions
    • Near-patient Workflow Solutions
  • News
  • Investors
    • Year in Review 2021
    • Corporate Calendar
    • Financial Reports
    • Leadership
    • General Meetings
    • Other Regulated Information
    • Advisor and Investor Contacts
    • AIM Rule 26 information
    • Corporate Governance
  • Our People
    • Careers
  • Contact
  • English
    • French
  • About
    • Board & Management
    • Business Development
  • Diagnostic Areas
    • COVID-19
    • Intelligent Innovation
  • Products & Solutions
    • Near-patient Workflow Solutions
  • News
  • Investors
    • Year in Review 2021
    • Corporate Calendar
    • Financial Reports
    • Leadership
    • General Meetings
    • Other Regulated Information
    • Advisor and Investor Contacts
    • AIM Rule 26 information
    • Corporate Governance
  • Our People
    • Careers
  • Contact
  • English
    • French
Search:

19 Feb Exercise of Warrants and Issue of Equity

Posted at 08:14h in Board, Novacyt Group, Products

Paris, France and Camberley, UK – 19 February 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has received notice from YA...

Read More

18 Feb Exercise of Warrants and Issue of Equity

Posted at 08:14h in Board, Novacyt Group, Products

Paris, France and Camberley, UK – 18 February 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has received notice from YA...

Read More

18 Feb Exercice de bons de souscription et émission d’actions

Posted at 08:10h in Board, Novacyt Group, Products

Paris, France et Camberley, Royaume-Uni – 18 février 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce qu'elle a reçu de YA II...

Read More

17 Feb Lancement du nouveau test CE-IVD du coronavirus

Posted at 12:20h in Board, Novacyt Group, Products

Paris, France et Camberley, Royaume-Uni – 17 février 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, a le plaisir d'annoncer que sa division...

Read More

17 Feb Launch of CE-IVD Marked novel coronavirus test

Posted at 12:18h in Board, Novacyt Group, Products

Paris, France and Camberley, UK – 17 February 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce that its molecular diagnostics...

Read More

14 Feb Mise à jour sur le test du coronavirus approuvé par le marquage CE

Posted at 15:24h in Board, Novacyt Group, Products

Paris, France et Camberley, Royaume-Uni – 14 février 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, a le plaisir d'annoncer que, suite à son annonce...

Read More

14 Feb Update on CE Mark Approved coronavirus test

Posted at 15:22h in Board, Novacyt Group, Products

Paris, France and Camberley, UK – 14 February 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce that, further to its...

Read More

07 Feb Informations à propos du nouveau test sur le coronavirus

Posted at 07:00h in Board, Novacyt Group, Products

Paris, France et Camberley, Royaume-Uni – 7 février 2020 –Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, fournit une information actualisée suite au lancement de son test RUO...

Read More

07 Feb Update on novel coronavirus test

Posted at 07:00h in Board, Novacyt Group, Products

Paris, France and Camberley, UK – 7 February 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, provides an update following the launch of its...

Read More

05 Feb Primerdesign launches Coronavirus qPCR pathogen detection kit designed to detect the latest outbreak 2019-nCoV

Posted at 11:55h in Blog, COVID-19, genesig qPCR Detection Kits, News

In light of recent events unfolding in China with the outbreak of Coronavirus (2019-nCoV) spreading across to other countries with over 17,000 infected and over 550 fatalities, Primerdesign has launched...

Read More
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
Recent Posts
  • DHSC Claim update – Trial date listed

    30 January, 2023
  • Full Year 2022 Trading Update

    26 January, 2023
  • Holdings in Company

    06 January, 2023
  • Non-Executive Director Change

    07 December, 2022
  • Approval of genesig® COVID-19 3G PCR test in the UK under CTDA legislation

    06 December, 2022
Archives
Categories

About


Novacyt is a leading global diagnostics company. We protect people and society in the fight against infectious diseases.

Company


York House, School Lane, Chandlers Ford, Eastleigh, SO53 4DG

Novacyt UK Holdings - 12031776
Novacyt SA - 491062527

Latest reports


Investor Presentation September 2022
Year in Review 2021

© 2022 Novacyt | Privacy Policy | Copyright | Terms & Conditions

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT